How does bacterial infection impact the early stages of tumor formation in the colon and how could this be mechanistically explained?
Bacterial infection impacts early colorectal tumorigenesis by inducing genomic instability through specialized genotoxins, subverting the protective mucosal barrier via secreted proteases, and hijacking host signaling pathways to promote cell survival and proliferation. Mechanistically, these processes are driven by the expansion of pathogenic strains like pks+ Escherichia coli and Salmonella Typhimurium, which utilize bacterial effectors to bypass host defenses and directly mutate or modify the epithelial landscape.
Genotoxic Induction and Mutational Signatures
The most direct mechanism of bacterial-driven initiation involves the production of genotoxins that cause structural DNA damage.
* Colibactin-mediated DNA Damage: Strains of E. coli harboring the pks genomic island produce colibactin, a genotoxin that induces double-strand breaks (DSBs) and interstrand crosslinks (ICLs) in intestinal epithelial cells (Direct, High; PMID: 32106218, PMID: 40508162).
* Specific Mutational Signatures: Prolonged exposure to pks+ E. coli in human intestinal organoids results in a distinct mutational signature characterized by T>N single base substitutions (SBS-pks) at ATA, ATT, and TTT motifs, and single T deletions at T homopolymers (ID-pks) (Direct, High; PMID: 32106218).
* Driver Gene Mutations: These signatures are found in clinical colorectal cancer (CRC) metastases and correlate with mutations in the APC tumor suppressor gene, suggesting bacteria-induced mutations are early events in tumorigenesis (Direct, High; PMID: 32106218).
* Cytopathic Effects: pks+ E. coli infection leads to megalocytosis (enlarged nuclei and cytoplasm) in primary colon epithelial cells, indicative of genomic stress and cell cycle arrest (Direct, High; PMID: 31990962).
Subversion of the Mucosal Barrier
For genotoxins like colibactin to act, bacteria must bypass the protective mucus layer, a process facilitated by specific bacterial proteases.
* Vat-mediated Penetration: The serine protease autotransporter Vat, found in 92% of pks+ E. coli genomes, degrades mucins (including MUC2), allowing bacteria to reach the epithelial surface (Direct, High; PMID: 40508162).
* Enhanced Genotoxicity: Deletion of the vat gene significantly reduces the ability of pks+ E. coli to induce γ-H2AX foci (a marker of DSBs) and reduces tumor burden in Apc Min/+ mice (Direct, High; PMID: 40508162).
* Inflammation and Accessibility: Chronic inflammation, such as that seen in Il10-/- mice, supports the expansion of pks+ E. coli and decreases the production of protective mucins, facilitating bacterial adherence and genotoxin delivery (Direct, High; PMID: 22903521).
Manipulation of Host Signaling and Post-Translational Modifications
Pathogenic bacteria utilize effectors to hijack signaling pathways that regulate cell proliferation, apoptosis, and the tumor microenvironment.
* Wnt/β-catenin Activation: Salmonella Typhimurium effectors, such as AvrA, activate the β-catenin signaling pathway, which is a "gatekeeper" for crypt cell proliferation (Direct, High; PMID: 35089888).
* CDC42 Deacetylation: Salmonella infection activates the host deacetylase SIRT2, which deacetylates CDC42 at lysine 153 (K153). This modification blocks the binding of CDC42 to its effector PAK4, leading to reduced phosphorylation of p38 and JNK, thereby inhibiting apoptosis and promoting cell survival (Direct, High; PMID: 36812247).
* Inflammatory Crosstalk: Bacterial effectors also activate STAT3 and NF-κB pathways, creating a pro-tumorigenic microenvironment through the release of cytokines like IL-6 and TNF-α (Direct, High; PMID: 35089888, PMID: 22903521).
Microbiota Dysbiosis and Metabolic Changes
The early stages of adenoma formation are also associated with shifts in microbial metabolites that normally exert anti-tumor effects.
* GABA Depletion: In models of sporadic colon cancer, the frequency of microbial genes involved in producing Gamma-aminobutyric acid (GABA), such as glutamate decarboxylase (GAD), decreases significantly at the onset of adenoma development (Direct, Medium; PMID: 38886975).
* Anti-proliferative Loss: Since GABA has been shown to inhibit colon cancer cell proliferation and migration via GABA receptors, its depletion may remove a natural check on early tumor growth (Direct, High; PMID: 38886975).
Synthesis
The evidence establishes that bacterial infection promotes early colon tumorigenesis through a multi-step "two-hit" model. Initially, inflammation or dietary factors cause dysbiosis, leading to the expansion of genotoxic and barrier-degrading bacteria (Derived, High; PMID: 22903521). These bacteria deliver genotoxins like colibactin, which induce specific mutations in genes like APC (Derived, High; PMID: 32106218). Concurrently, bacterial effectors such as AvrA and the manipulation of PTMs like CDC42 deacetylation suppress apoptosis and activate proliferative pathways (Derived, High; PMID: 35089888, PMID: 36812247). Together, these mechanisms transform the healthy colonic epithelium into a site of active neoplastic initiation.
Unverified Citations
The following sources failed to support their assigned claims after 3 verification rounds designed to ensure only high-confidence, relevant references are retained:
- PMID:23457644 — coli infection leads to megalocytosis (enlarged nuclei and cytoplasm), cell swelling, and syncytium formation in primar...*
Failed: conclusion — While the paper describes megalocytosis, it does not mention 'cell swelling' or 'syncytium formation' in primary colon epithelial cells. - PMID:40508162 — Initially, inflammation or dietary factors cause dysbiosis, leading to the expansion of genotoxic and barrier-degrading ...
Failed: conclusion — The paper mentions lifestyle-associated dysbiosis in the introduction but does not provide experimental data or findings regarding the expansion of genotoxic bacteria specifically due to inflammation or diet. - PMID:40508162 — These bacteria use proteases like Vat to penetrate the mucus layer and deliver genotoxins like colibactin, which induce ...
Failed: entities — The paper does not mention or study the APC gene as a target for colibactin-induced mutations; it uses the APC Min/+ mouse as a model system but does not attribute the mutations to the APC gene itself.
Beyond the Vacuolating autotransporter toxin (Vat), several other bacterial proteases—primarily from the serine protease autotransporters of enterobacteria (SPATEs) class—have been identified as contributors to the degradation of the intestinal mucus barrier, a critical step that enables genotoxic bacteria to initiate tumorigenesis.
Key Bacterial Proteases in Mucosal Barrier Degradation
According to research into pathogenic Escherichia coli and other enteric pathogens, the following proteases subvert the mucus layer:
- Pic (Protease involved in intestinal colonization): Found in enteroaggregative E. coli (EAEC) and Shigella flexneri, this protease can degrade a variety of mucins, including MUC2 and MUC5AC. Its activity reduces mucus viscosity and enhances the ability of these strains to colonize the host (Direct, High; PMID: 40508162) «✓ PMID:40508162».
- EatA: An autotransporter found in enterotoxigenic E. coli (ETEC) that is involved in the degradation of mucins. This degradation facilitates the delivery of bacterial toxins directly to the intestinal epithelial cell surface (Direct, High; PMID: 40508162) «✓ PMID:40508162».
- StcE: A metalloprotease identified in enterohaemorrhagic E. coli (EHEC) O157:H7. It contributes to the subversion of the mucus barrier by aiding the attachment of the bacteria to the intestinal epithelium (Direct, High; PMID: 40508162) «✓ PMID:40508162».
- Hbp/Tsh (Hemoglobin-binding protease/Temperature-sensitive hemagglutinin): These mucinases share approximately 79% sequence similarity with Vat and possess similar mucinase activity. They are positively associated with the B2 phylogroup and extraintestinal pathogenic E. coli (Direct, High; PMID: 40508162).
Mechanistic Context in Colorectal Tumorigenesis
The identification of these proteases is significant in the context of colorectal cancer initiation because the protective mucus layer (primarily composed of MUC2) serves as a physical barrier against genotoxins like colibactin.
- Enabling Genotoxicity: Genotoxic effects of pks+ E. coli (which produce colibactin) are contact-dependent. Proteases like Vat and Pic allow bacteria to penetrate the mucus, reducing the distance between the bacteria and epithelial cells. This proximity is essential for colibactin to induce double-strand DNA breaks (Direct, High; PMID: 40508162) «✓ PMID:40508162».
- Prevalence in CRC Patients: While the vat gene is most prevalent in pks+ E. coli isolated from CRC patients (92%), the pic gene is also present in a significant subset (42%) of these genotoxic strains (Direct, High; PMID: 40508162) «✓ PMID:40508162».
- Tumorigenesis Promotion: Experimental disruption of the mucus barrier (e.g., via chemical agents or genetic depletion of MUC2) is associated with increased DNA damage and the spontaneous development of invasive adenocarcinoma. Bacterial proteases mimic this disruption, effectively serving as "drivers" for early-stage tumor development (Direct, High; PMID: 40508162) «✓ PMID:40508162».